Detection of patients at high risk for nonocclusive mesenteric ischemia after cardiovascular surgery

Table 1 Background of 12 NOMI patients

No	Age	Sex	Surgery	Emergency	Initial symptoms/findings	Duration between Surgery and NOMI(days)	Patient state at the onset of NOMI					Result
No	Age	Sex	Surgery	Emergency	Initial symptoms/findings	Duration between Surgery and NOMI(days)	NOE > 0.10 μg/kg/min	LOS	Sepsis	HD	Sedation	Result
1	83	Male	TAR	No	Hyperlactatemia	13	Yes	No	No	Yes	Yes	Death
2	81	Male	OPCABG	No	Hematochezia	64	No	No	Yes	Yes	Yes	Death
3	67	Male	OPCABG	No	Abdominal pain	13	No	No	No	No	No	Survival
4	66	Male	OPCABG	No	Abdominal pain	34	No	No	Yes	No	No	Survival
5	77	Female	AAR	Yes	Hyperlactatemia	17	Yes	Yes	No	Yes	Yes	Death
6	81	Male	CABG	No	Hyperlactatemia	30	Yes	Yes	No	No	No	Death
7	86	Male	OPCABG	Yes	Hyperlactetamia	8	Yes	Yes	No	Yes	Yes	Death
8	69	Female	OPCABG	No	Hyperlactetamia	11	Yes	No	No	Yes	Yes	Death
9	67	Female	CABG	No	Hyperlactatemia	2	Yes	No	No	Yes	Yes	Death
10	76	Female	MVP, TAP	No	Vomiting	15	No	No	No	No	No	Survival
11	79	Male	CABG, MVR	No	Hypotension	15	Yes	Yes	Yes	Yes	Yes	Death
12	64	Male	CABG	Yes	Hyperlactatemia	5	No	Yes	No	Yes	Yes	Death

NOMI non-occlusive mesenteric ischemia, NOE norepinephrine, LOS low output syndrome, HD hemodialysis, TAR Total Arch Aortic Replacement, OPCABG off-pump coronary artery bypass graft surgery, AAR Ascending Aortic Replacement, CABG coronary artery bypass graft surgery, MVP mitral valve plasty, TAP tricuspid annuloplasty, MVR mitral valve replacement

ISSN: 1749-8090